发明人张德明,刘建华,郑宇鹏. "一种瑞替加滨杂质13的合成方法" [P]. 中国发明专利, 专利号 CN 114437287 A, 授权公告日 2020-03-23.
发明人李文辉,黄志刚,徐明华. "Method for the Synthesis of Retigabine impurity 13" [P]. 中国发明专利, 专利号 CN 108714863 A, 授权公告日 2015-07-20.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 瑞替加滨杂质13 in Pharmaceutical Formulations". Molecules, 2020, 263, (9), 1514-1538.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 瑞替加滨杂质13 as an Impurity". J. Chromatogr. A, 2016, 1052, 7271-7292.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Retigabine impurity 13 Using HRMS and NMR". Anal. Methods, 2017, 1978, 9333-9354.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 瑞替加滨杂质13 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2013, 2274, (8), 4464-4467.